Literature DB >> 6248744

Neuromuscular junction macromolecules in the pathogenesis of amyotrophic leteral sclerosis.

B W Festoff.   

Abstract

An hypothesis regarding the pathogenesis of amyotrophic lateral sclerosis is presented, which places emphasis on extraneural cells. Classical experimental denervation is compared and contrasted with motor neuron disease, both from information in the literature as well as concepts deriving from the hypothesis. Background information regarding neuromuscular junction-specific (16S) acetylcholinesterase and a basal lamina-enriched surface glycoprotein (fibronectin) are presented, which suggest not only their mutual interaction, but likely parallel regulation on muscle cell surfaces by the motor nerve. Since 16S acetylcholinesterase likely contains basal lamina-type collagen and fibronectin specifically associates with collagen, a model relating activation of latent collagenase enzyme in amyotrophic lateral sclerosis is described. It is suggested that continued degeneration, including transneuronal effects, of the motor system ensues from random, continuous loss of nerve-muscle adherence resulting from collagen resorption at the neuromuscular junction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248744     DOI: 10.1016/0306-9877(80)90078-x

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

1.  Rapid neural regulation of muscle urokinase-like plasminogen activator as defined by nerve crush.

Authors:  D Hantaï; J S Rao; B W Festoff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 2.  Amyotrophic lateral sclerosis: current and future treatment strategies.

Authors:  B W Festoff
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

3.  Decrease in plasminogen activator correlates with synapse elimination during neonatal development of mouse skeletal muscle.

Authors:  D Hantaï; J S Rao; C Kahler; B W Festoff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Embryonic brain extract induces collagen biosynthesis in cultured muscle cells: involvement in acetylcholine receptor aggregation.

Authors:  C Kalcheim; Z Vogel; D Duksin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

Review 5.  Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.

Authors:  Barry W Festoff; Zhiming Suo; Bruce A Citron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  Plasminogen activator in mammalian skeletal muscle: characteristics of effect of denervation on urokinase-like and tissue activator.

Authors:  B W Festoff; D Hantaï; J Soria; A Thomaïdis; C Soria
Journal:  J Cell Biol       Date:  1986-10       Impact factor: 10.539

Review 7.  The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies.

Authors:  Barry W Festoff; Chris Dockendorff
Journal:  Biomolecules       Date:  2021-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.